FLANDERSBIO
0863.763.620 · rovalta.com · 22/09/2026
FLANDERSBIO
Company — Normal situation.
Overview
What does FLANDERSBIO do?
FLANDERSBIO is a company registered in Belgium. It employs on average 5,6 ETP workers (FTE).
Joint committees (2)
- 200
- 335
Trend over 17 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||
| Revenue | 898 k € | -16.0% | 1,1 M € | – | – | – | – | – | – | – | – | – | – | – | – | – | 274,2 k € | +53.7% | 178,4 k € | ||||||||||||||
| EBITDA | -327,4 k € | -1148% | 31,2 k € | +138% | -83,2 k € | -124% | 353,9 k € | +2.8% | 344,3 k € | +6.1% | 324,4 k € | +433% | 60,8 k € | +152% | -116,9 k € | -829% | -12,6 k € | -570% | -1,9 k € | -103% | 57,3 k € | -69.4% | 187,3 k € | +251% | 53,4 k € | -37.1% | 84,8 k € | -31.5% | 123,7 k € | +2054% | -6,3 k € | +68.9% | -20,4 k € |
| Operating result | -369,2 k € | -3921% | 9,7 k € | +109% | -106,4 k € | -132% | 330,8 k € | +0.3% | 329,6 k € | +10.0% | 299,7 k € | +1481% | 19 k € | +113% | -145,5 k € | -245% | -42,1 k € | -169% | -15,7 k € | -154% | 29,2 k € | -79.2% | 140,5 k € | +515% | 22,8 k € | -55.1% | 50,9 k € | -45.2% | 93 k € | +533% | -21,5 k € | +25.7% | -28,9 k € |
| Net result | -355,7 k € | -2805% | 13,1 k € | +112% | -108,9 k € | -134% | 323,5 k € | +0.5% | 322,1 k € | +23.2% | 261,4 k € | +1697% | 14,5 k € | +110% | -145,2 k € | -445% | -26,6 k € | +30.8% | -38,5 k € | -256% | 24,8 k € | -82.0% | 137,4 k € | +1550% | 8,3 k € | -68.2% | 26,2 k € | -69.5% | 85,8 k € | +485% | -22,3 k € | +15.8% | -26,5 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||
| Equity | 825,7 k € | -30.1% | 1,2 M € | +1.1% | 1,2 M € | -8.5% | 1,3 M € | +33.9% | 953,6 k € | +51.0% | 631,6 k € | +70.6% | 370,2 k € | +4.1% | 355,7 k € | -29.0% | 500,9 k € | -5.1% | 527,6 k € | -6.8% | 566,1 k € | +4.6% | 541,3 k € | +34.0% | 403,9 k € | +2.1% | 395,6 k € | +7.1% | 369,4 k € | +30.3% | 283,6 k € | -7.3% | 305,9 k € |
| Total assets | 1,2 M € | -30.9% | 1,7 M € | +16.2% | 1,5 M € | -2.5% | 1,5 M € | +30.3% | 1,1 M € | +0.8% | 1,1 M € | +36.7% | 829,8 k € | -38.9% | 1,4 M € | +53.2% | 886,4 k € | -3.0% | 914,1 k € | +3.6% | 882,8 k € | +33.4% | 662 k € | +10.8% | 597,6 k € | -4.6% | 626,7 k € | -7.0% | 673,7 k € | +46.8% | 458,9 k € | -2.8% | 472,2 k € |
| Cash | 46,5 k € | -70.6% | 158,2 k € | -83.1% | 934,1 k € | -3.7% | 969,9 k € | +80.5% | 537,3 k € | -7.2% | 579,3 k € | +191% | 198,9 k € | +12.1% | 177,5 k € | -32.9% | 264,5 k € | +7.4% | 246,2 k € | -0.3% | 247 k € | -8.4% | 269,7 k € | +93.4% | 139,5 k € | -35.5% | 216,4 k € | -11.9% | 245,7 k € | +38.1% | 177,9 k € | +85.3% | 96 k € |
| Debts | 176,4 k € | +10.7% | 159,4 k € | +7.9% | 147,7 k € | +18.0% | 125,2 k € | +29.9% | 96,4 k € | -37.9% | 155,3 k € | +41.0% | 110,1 k € | -65.4% | 317,8 k € | +115% | 147,5 k € | +0.2% | 147,3 k € | -7.9% | 159,9 k € | +98.0% | 80,8 k € | -30.1% | 115,5 k € | -9.2% | 127,2 k € | -35.0% | 195,6 k € | +79.1% | 109,2 k € | +53.2% | 71,3 k € |
| Other | |||||||||||||||||||||||||||||||||
| Workforce | 5,6 ETP | -16.4% | 6,7 ETP | -2.9% | 6,9 ETP | +21.1% | 5,7 ETP | 0.0% | 5,7 ETP | +14.0% | 5,0 ETP | +4.2% | 4,8 ETP | -30.4% | 6,9 ETP | -6.8% | 7,4 ETP | +8.8% | 6,8 ETP | +11.5% | 6,1 ETP | +8.9% | 5,6 ETP | 0.0% | 5,6 ETP | -13.8% | 6,5 ETP | +4.8% | 6,2 ETP | -7.5% | 6,7 ETP | +19.6% | 5,6 ETP |
Board of directors
Seen on filing of 31/12/2024 · 18 active · 159 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 10/06/2025 | 18/07/2024 | 25/05/2023 | 12/07/2022 | 08/07/2021 | 16/07/2020 |
| General meeting | 27/05/2025 | 20/06/2024 | 27/04/2023 | 30/06/2022 | 24/06/2021 | 23/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
19 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 27/05/2025 | 10/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 20/06/2024 | 18/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 27/04/2023 | 25/05/2023 | Dutch | |
| Abridged model | 31/12/2021 | 30/06/2022 | 12/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 24/06/2021 | 08/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 23/06/2020 | 16/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 28/03/2019 | 26/04/2019 | Dutch | |
| Abridged model | 31/12/2017 | 21/06/2018 | 11/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 20/04/2017 | 06/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 21/04/2016 | 09/05/2016 | Dutch | |
| Abridged model | 31/12/2014 | 26/06/2015 | 09/09/2015 | Dutch | |
| Abridged model | 31/12/2013 | 26/05/2014 | 18/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 13/06/2013 | 20/06/2013 | Dutch | |
| Abridged model | 31/12/2011 | 18/04/2012 | 10/05/2012 | Dutch | |
| Abridged model | 31/12/2010 | 07/04/2011 | 04/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 22/04/2010 | 19/05/2010 | Dutch | |
| Abridged model | 31/12/2008 | 23/04/2009 | 18/06/2009 | Dutch | |
| Abridged model | 31/12/2007 | 07/03/2008 | 09/05/2008 | Dutch | |
| Abridged model | 31/12/2006 | 16/03/2007 | 25/02/2008 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2024 · 18 active · 159 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-355,7 k €↓
- 2023Annual accounts 202313,1 k €↑
- 2022Annual accounts 2022-108,9 k €↓
- 2022Name changeflanders.bio
- 2021Annual accounts 2021323,5 k €↑
- 2021Name changeFLANDERSBIO
- 2020Annual accounts 2020322,1 k €↑
- 2019Annual accounts 2019261,4 k €↑
- 2018Annual accounts 201814,5 k €↑
- 2017Annual accounts 2017-145,2 k €↓
- 2016Annual accounts 2016-26,6 k €↑
- 2015Annual accounts 2015-38,5 k €↓
- 2014Annual accounts 201424,8 k €↓
- 2013Annual accounts 2013137,4 k €↑
- 2012Annual accounts 20128,3 k €↓
- 2011Annual accounts 201126,2 k €↓
- 2010Annual accounts 201085,8 k €↑
- 2009Annual accounts 2009-22,3 k €↑
- 2008Annual accounts 2008-26,5 k €